Rigicon is a global medical technology company exclusively focused on designing and manufacturing innovative prosthetic urology solutions.
Rigicon is a global medical technology company exclusively focused on designing and manufacturing innovative prosthetic urology solutions.
Rigicon is a global medical technology company exclusively focused on designing and manufacturing innovative prosthetic urology solutions. Our mission is simple: to restore quality of life for men facing erectile dysfunction (ED) and urinary incontinence.
We are not just a manufacturer; we are a scientific partner committed to advancing the standard of care. Our technologies are currently implanted in over 40 countries, and we are now bringing this global experience to the United States through the UNITED Clinical Study.
Our commitment to patient safety and product excellence is overseen by the Rigicon Board of Medical & Scientific Advisors. This independent board includes some of the world's most respected prosthetic urologists, ensuring our clinical trials and technologies meet the highest scientific standards.
A global authority in prosthetic urology with 50+ years of experience.
Leading expert in genital reconstruction and sexual medicine.
Distinguished expert in sexual medicine and male health.
Top-volume implant surgeon and national expert.
...and other distinguished global thought leaders
We believe in transparency and data. Rigicon technologies are supported by peer-reviewed research published in leading medical journals, including The Journal of Sexual Medicine, BJU International, and Nature Reviews Urology.
While the Infla10® Pulse™ IPP is an investigational device in the U.S., it has been the subject of numerous international studies evaluating its performance and safety profile worldwide.
Note: Clicking this link will take you to the global corporate website.
The Rigicon Infla10® Pulse™ Inflatable Penile Prosthesis is an investigational device in the United States and is limited by Federal law to investigational use. The UNITED Clinical Study is being conducted to evaluate its safety and effectiveness for U.S. patients.
References to global availability or international clinical data are for informational purposes only and do not constitute a claim of safety or effectiveness for the device within the United States.